Sem-P is indicated: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
doi:10.1021/acs.jmedchem.5b00726 Rubino DM, Greenway FL, Khalid U, et al
Altrettanto significativa la notizia recente che lo studio FLOW, in pi di 3,500 pazienti con diabete di tipo 2 e malattia renale cronica, stato interrotto per eccesso di efficacia del trattamento con semaglutide
FDA-approved options for chronic weight management include: Other GLP-1 receptor agonists (semaglutide, liraglutide) Combination therapies (phentermine-topiramate ER, naltrexone-bupropion ER) Orlistat Metformin for patients with diabetes or prediabetes, which provides modest weight-neutral or weight-loss effects Realistic expectations are essential
A sudden stall after consistent progress, particularly one that coincides with a new vial or a storage incident, suggests the new vial may have degraded peptide
That's how confident I am